Faculty profile
Aneesh Thakur
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy.
Scientific reports · 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026
Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies.
Biotechnology advances · 2024
Latest funding
- $1,170,450
Studies into improved broadly reactive and protective vaccination strategies for high consequence Bunyaviruses
CIHR · 2026 · Co-investigator
- $100,000
Inducing T cell immunity against gonorrhea in the female genital tract by messenger RNA vaccines
CIHR · 2024 · Nominated PI
- $40,000
Inducing respiratory mucosal immunity in cattle by design of next-generation thermostable ribonucleic acid vaccines
NSERC · 2024 · Principal investigator
6 publications.
Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy.
Ongun M, Kola NS, Patel D, da Costa Rodrigues T, Schmidt ST, Lokras AG, Franzyk H, Paludan SR, Rades T, Thakur A, Foged C
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ
Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies.
Eş I, Thakur A, Mousavi Khaneghah A, Foged C, de la Torre LG
RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.
Kola NS, Patel D, Thakur A
Intracellular Pathogens: Infection, Immunity, and Intervention.
Martens-Koop A, Thakur A
Editorial: Intracellular bacterial pathogens: Infection, immunity and interventions.
Verma S, Thakur A
Studies into improved broadly reactive and protective vaccination strategies for high consequence Bunyaviruses
Principal investigators: Warner, Bryce
Keywords: Bunyaviruses; Hantaviruses; Virology
Inducing T cell immunity against gonorrhea in the female genital tract by messenger RNA vaccines
Principal investigators: Thakur, Aneesh
Keywords: Animal Models; Drug Delivery; Female Genital Tract; Flow Cytometry; Formulation; Gonorrhea; Messenger Rna; Mucosal Immunity; Nanoparticles; Resident Memory T Cells
Inducing respiratory mucosal immunity in cattle by design of next-generation thermostable ribonucleic acid vaccines
Principal investigators: Thakur, Aneesh
Keywords: cattle; rna; nanoparticles; formulation; drug delivery; immunology; mucosal immunity; vaccines; particle engineering; thermostability
Engineering next-generation messenger RNA vaccines: Reinforcing the mucosal barriers by thermostable dry powder vaccines for inhalation
Principal investigators: Thakur, Aneesh
Keywords: Animal Models; Drug Delivery; Flow Cytometry; Formulation; Inhalable Vaccines; Messenger Rna; Mucosal Immunity; Nanoparticles; Particle Engineering; Thermostability
Inducing respiratory mucosal immunity in cattle by design of next-generation thermostable ribonucleic acid vaccines
Principal investigators: Thakur, Aneesh
Keywords: cattle; rna; nanoparticles; formulation; drug delivery; immunology; mucosal immunity; vaccines; particle engineering; thermostability
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Shahid Ahmed and Gary Groot: 6 shared papers
- Andrew Freywald and Anand Krishnan: 4 shared papers
- Andrew Freywald and Shahid Ahmed: 3 shared papers
- Andrew Freywald and Gary Groot: 2 shared papers
- Graham Dellaire and Christopher Eskiw: 2 shared papers
- Shahid Ahmed and Anand Krishnan: 2 shared papers
- Sabine Mai and Andrew Freywald: 1 shared paper
- Sabine Mai and Graham Dellaire: 1 shared paper
- Sabine Mai and Shahid Ahmed: 1 shared paper
- Sabine Mai and Christopher Eskiw: 1 shared paper
- Sabine Mai and Gary Groot: 1 shared paper
- Sabine Mai and Anand Krishnan: 1 shared paper
- Sabine Mai and Aneesh Thakur: 1 shared paper
- Andrew Freywald and Graham Dellaire: 1 shared paper
- Andrew Freywald and Christopher Eskiw: 1 shared paper
- Andrew Freywald and Aneesh Thakur: 1 shared paper
- Graham Dellaire and Aneesh Thakur: 1 shared paper
- Shahid Ahmed and Aneesh Thakur: 1 shared paper
- Christopher Eskiw and Aneesh Thakur: 1 shared paper
- Gary Groot and Aneesh Thakur: 1 shared paper
- Anand Krishnan and Aneesh Thakur: 1 shared paper
- Vaccine and Infectious Disease Organization
- Oncology
- Biochemistry, Microbiology & Immunology
- Community Health and Epidemiology
- Pathology
- Physiology
- Medicine/Oncology
- Other
Co-authors at University of Saskatchewan, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Sabine Mai
Physiology
1 shared papers, latest 2026
Andrew Freywald
Oncology
1 shared papers, latest 2026
Graham Dellaire
Pathology
1 shared papers, latest 2026
Shahid Ahmed
Medicine/Oncology
1 shared papers, latest 2026
Christopher Eskiw
Biochemistry, Microbiology & Immunology
1 shared papers, latest 2026
Gary Groot
Community Health and Epidemiology
1 shared papers, latest 2026
Anand Krishnan
Faculty
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.